Form D · Biotechnology

Biothera Holding Corp.

Eagan, MN · CIK 0001624720

Offering snapshot reported Mar 15, 2018 · SEC filing

Reported sold: $14.6M
Investors reported: 139
Minimum accepted: $0
First sale: Apr 26, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$1,075,000 → $14,642,590
Reported investors3 → 139

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 15, 2018	Amendment	$14,642,590	$13,567,590vs May 11, 2017	139	SEC filing
May 11, 2017	Initial	$1,075,000	No comparison	3	SEC filing
Dec 10, 2014	Initial	$1,588,130	No comparison	28	SEC filing

Offering details

Securities: Equity, Option to acquire, Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-286581

Class A Common Stock and Warrants to Purchase Class A Common Stock

Source: Form D, filed Mar 15, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Bruce L.A. Carter	Director
Daniel Conners	Director, Executive
William L. Gacki	Executive
Alex Giaquinto	Director
Robert Hill	Director
Annalisa Jenkins	Director
Steven Karel	Director, Executive
Steve King	Director
Andrew La Frence	Director
Richard Mueller	Director, Executive
Dick Pfister	Director
Dwight Porter	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

3388 Mike Collins Drive, Suite A
Eagan, MN, 55121